This report presents the results of a study that dealt specifically with effective communication around the benefit and risk balance of vaccination people’s risk perceptions around vaccines and diseases, and approaches to enhancing communication about the safety and effectiveness of vaccines.
This protocol describes a survey undertaken to acquire a snapshot of the distribution of Clostridioides difficile strains in tertiary acute care hospitals in the European Union/European Economic Area (EU/EEA) in 2022–2023
This reporting protocol is for the 2024 data call for antimicrobial resistance (AMR) surveillance data, collected by the European Antimicrobial Resistance Surveillance Network (EARS-Net) for 2023.
Sample size calculation is an essential step in ensuring that analysis of the data which are collected through urveillance systems can support the desired public health objective(s). The main aim of sample size calculations is to determine the sample size needed from the population under study to possibly detect a statistically significant result.
The purpose of this guide is to complement the handbook published in 2014 by offering practical, operational
guidance on how to design, develop, conduct and evaluate tabletop and functional exercises.
This assessment tool, which will be used during the country visits to Western Balkans and Türkiye, aims to provide ECDC with a good understanding of national communicable disease surveillance systems.
This report seeks to review the progress made in the ECDC response plan to control and manage the threat of drug-resistant gonorrhoea in Europe over the preceding two years, using the data collected for 2019.
The toolkit contains template materials and some suggested key messages focusing on self-medication with antibiotics, ideas for awareness raising activities, and suggested tactics for getting the messages across to the general public regarding prudent use of antibiotics, especially to people self-medicating with antibiotics.
The Protocol is targeted at the national public health reference laboratories to guide the susceptibility testing needed for EU surveillance and the reporting to ECDC.
This document is intended for hospital staff that use HelicsWin.Net to collect or administer data collected using ECDC’s HAI-Net surveillance of healthcare-associated infections methods (HAINet PPS and ICU).